Hematologic Cancers

Hematologic CancersHematologic cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. A chief a part of blood-based investigation goes on during this field. Leukaemia mainly affects the white blood cells (WBCs) and are closely linked to the lymphomas and some of them are deeply related to the adult T cells leukaemia, these disorders comes under the lymph proliferative disorders. The cancer which originates from WBCs (white blood cells) is known as lymphoma and this type of disorder is mainly seen in Hodgkin lymphoma these diseases can be treated with hematopoietic stem cell transplantation, radiation therapy and chemotherapy. The bone marrow in which many white blood cells develop that leads to multiple myeloma.

  • Hodgkin and non-Hodgkin lymphoma
  • Myelogenous leukemia
  • Acute lymphocytic
  • Chronic lymphocytic
  • Multiple Myeloma

Related Conference of Hematologic Cancers

January 24-25, 2022

2nd European Congress on Hematology

Prague, Czech Republic
January 27-28, 2022

2nd World Congress on Hematology and Genetic Blood Disorders

Prague, Czech Republic
March 14-15, 2022

20th World Hematology Congress

London, UK

Hematologic Cancers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in